Are Secret Deals Among Drug Companies Costing You Money?
October 27, 2011
The U.S. Federal Trade Commission (“FTC”) has reported that name-brand drug manufacturers will cost U.S. taxpayers billions of dollars over a 10 year period by paying generic drug manufacturers to delay their introduction of lower-cost generic alternatives to brand-name drugs. The[...]
Continue Reading
Direct-To-Consumer Advertising Of Drugs
June 13, 2011
Direct-to-consumer (DTC) advertising of prescription medications has been an issue since the late 1990s when the large pharmaceutical companies greatly increased their DTC advertising of their new drugs. Prior to the 1990s, the drug companies mainly focused their marketing efforts on those who pres[...]
Continue Reading
